31 August 2021

Trends in kinase drug discovery: targets, indications and inhibitor design

Abstract: The FDA approval of imatinib in 2001 was a breakthrough in molecularly targeted cancer therapy and heralded the emergence of kinase inhibitors as a key […]
1 June 2021

Celtarys Research is attending BIODIGITAL 21

BIODIGITAL 21, the international meeting focused on biotechnology, is just around the corner and our CEO Sonia Martinez Arca will be present in the event. BIODIGITAL […]